KalVista Pharmaceuticals, Inc. (KALV)
16.90
+0.04
(+0.21%)
USD |
NASDAQ |
Dec 11, 13:20
KalVista Pharmaceuticals Market Cap: 853.98M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.615B |
| Revolution Medicines, Inc. | 15.21B |
| Silvergate Capital Corp. | 302.23M |
| Perspective Therapeutics, Inc. | 196.62M |
| Electromed, Inc. | 251.63M |
Market Cap Related Metrics
| PS Ratio | 58.61 |
| PEG Ratio | -0.4116 |
| Price to Book Value | 50.24 |
| Price | 16.90 |
| Earnings Yield | -23.75% |
| PEGY Ratio | -0.4116 |